Amalgamated Bank’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-63,389
| Closed | -$11.6M | – | 2200 |
|
|
2021
Q2 | $11.6M | Buy |
63,389
+51,432
| +430% | +$8.83M | 0.09% | 174 |
|
|
2021
Q1 | $1.83M | Sell |
11,957
-431
| -3% | -$66.7K | 0.07% | 268 |
|
|
2020
Q4 | $1.94M | Sell |
12,388
-30
| -0.2% | -$3.85K | 0.07% | 248 |
|
|
2020
Q3 | $1.42M | Sell |
12,418
-305
| -2% | -$32.9K | 0.06% | 315 |
|
|
2020
Q2 | $1.43M | Sell |
12,723
-21,622
| -63% | -$2.3M | 0.07% | 273 |
|
|
2020
Q1 | $3.08M | Sell |
34,345
-1,186
| -3% | -$116K | 0.08% | 229 |
|
|
2019
Q4 | $3.84M | Buy |
35,531
+1,061
| +3% | +$113K | 0.07% | 245 |
|
|
2019
Q3 | $3.38M | Buy |
34,470
+5,188
| +18% | +$585K | 0.07% | 247 |
|
|
2019
Q2 | $3.83M | Sell |
29,282
-2,134
| -7% | -$275K | 0.09% | 202 |
|
|
2019
Q1 | $4.25M | Buy |
31,416
+677
| +2% | +$84.2K | 0.1% | 185 |
|
|
2018
Q4 | $2.99M | Sell |
30,739
-810
| -3% | -$95.7K | 0.08% | 206 |
|
|
2018
Q3 | $4.39M | Sell |
31,549
-984
| -3% | -$123K | 0.11% | 182 |
|
|
2018
Q2 | $4.04M | Buy |
32,533
+1,852
| +6% | +$216K | 0.1% | 191 |
|
|
2018
Q1 | $3.42M | Buy |
30,681
+2,082
| +7% | +$249K | 0.09% | 204 |
|
|
2017
Q4 | $3.42M | Buy |
28,599
+2,513
| +10% | +$306K | 0.09% | 201 |
|
|
2017
Q3 | $3.66M | Buy |
26,086
+518
| +2% | +$70.4K | 0.11% | 174 |
|
|
2017
Q2 | $3.11M | Buy |
25,568
+9,006
| +54% | +$1.05M | 0.1% | 185 |
|
|
2017
Q1 | $2.01M | Sell |
16,562
-7,080
| -30% | -$913K | 0.1% | 185 |
|
|
2016
Q4 | $2.89M | Buy |
23,642
+4,098
| +21% | +$501K | 0.13% | 147 |
|
|
2016
Q3 | $2.4M | Buy |
19,544
+26
| +0.1% | +$3.35K | 0.14% | 128 |
|
|
2016
Q2 | $2.61M | Buy |
19,518
+10,881
| +126% | +$1.54M | 0.15% | 118 |
|
|
2016
Q1 | $1.2M | Buy |
8,637
+2,042
| +31% | +$300K | 0.12% | 152 |
|
|
2015
Q4 | $1.26M | Sell |
6,595
-1,666
| -20% | -$291K | 0.16% | 105 |
|
|
2015
Q3 | $1.29M | Buy |
8,261
+320
| +4% | +$58.4K | 0.14% | 126 |
|
|
2015
Q2 | $1.44M | Buy |
7,941
+1,006
| +15% | +$174K | 0.14% | 119 |
|
|
2015
Q1 | $1.2M | Buy |
6,935
+1,626
| +31% | +$294K | 0.15% | 141 |
|
|
2014
Q4 | $982K | Sell |
5,309
-773
| -13% | -$143K | 0.15% | 133 |
|
|
2014
Q3 | $1.01M | Buy |
6,082
+375
| +7% | +$61.6K | 0.15% | 134 |
|
|
2014
Q2 | $892K | Buy |
5,707
+718
| +14% | +$113K | 0.13% | 155 |
|
|
2014
Q1 | $759K | Sell |
4,989
-95
| -2% | -$15.1K | 0.13% | 168 |
|
|
2013
Q4 | $676K | Buy |
+5,084
| New | +$610K | 0.11% | 201 |
|
Other funds holding ALXN
BCI
NICM
TAIM
RG
CFO
MAM